154 related articles for article (PubMed ID: 34398393)
1. The prognostic significance of annexin A family in glioblastoma.
Xu H; Wu X; Dou Y; Zheng W
Ir J Med Sci; 2022 Aug; 191(4):1539-1547. PubMed ID: 34398393
[TBL] [Abstract][Full Text] [Related]
2. The miR155HG/miR-185/ANXA2 loop contributes to glioblastoma growth and progression.
Wu W; Yu T; Wu Y; Tian W; Zhang J; Wang Y
J Exp Clin Cancer Res; 2019 Mar; 38(1):133. PubMed ID: 30898167
[TBL] [Abstract][Full Text] [Related]
3. Annexin 2A sustains glioblastoma cell dissemination and proliferation.
Maule F; Bresolin S; Rampazzo E; Boso D; Della Puppa A; Esposito G; Porcù E; Mitola S; Lombardi G; Accordi B; Tumino M; Basso G; Persano L
Oncotarget; 2016 Aug; 7(34):54632-54649. PubMed ID: 27429043
[TBL] [Abstract][Full Text] [Related]
4. Expression levels and prognostic values of annexins in liver cancer.
Zhuang C; Wang P; Sun T; Zheng L; Ming L
Oncol Lett; 2019 Dec; 18(6):6657-6669. PubMed ID: 31807177
[TBL] [Abstract][Full Text] [Related]
5. Analysis of the Expression and Prognostic Value of Annexin Family Proteins in Bladder Cancer.
Wu W; Jia G; Chen L; Liu H; Xia S
Front Genet; 2021; 12():731625. PubMed ID: 34484309
[TBL] [Abstract][Full Text] [Related]
6. Annexin A2-STAT3-Oncostatin M receptor axis drives phenotypic and mesenchymal changes in glioblastoma.
Matsumoto Y; Ichikawa T; Kurozumi K; Otani Y; Fujimura A; Fujii K; Tomita Y; Hattori Y; Uneda A; Tsuboi N; Kaneda K; Makino K; Date I
Acta Neuropathol Commun; 2020 Apr; 8(1):42. PubMed ID: 32248843
[TBL] [Abstract][Full Text] [Related]
7. Annexin-1 is an oncogene in glioblastoma and causes tumour immune escape through the indirect upregulation of interleukin-8.
Chen R; Chen C; Han N; Guo W; Deng H; Wang Y; Ding Y; Zhang M
J Cell Mol Med; 2022 Aug; 26(15):4343-4356. PubMed ID: 35770335
[TBL] [Abstract][Full Text] [Related]
8. Identification of potential serum biomarkers of glioblastoma: serum osteopontin levels correlate with poor prognosis.
Sreekanthreddy P; Srinivasan H; Kumar DM; Nijaguna MB; Sridevi S; Vrinda M; Arivazhagan A; Balasubramaniam A; Hegde AS; Chandramouli BA; Santosh V; Rao MR; Kondaiah P; Somasundaram K
Cancer Epidemiol Biomarkers Prev; 2010 Jun; 19(6):1409-22. PubMed ID: 20530493
[TBL] [Abstract][Full Text] [Related]
9. S100A11 functions as novel oncogene in glioblastoma via S100A11/ANXA2/NF-κB positive feedback loop.
Tu Y; Xie P; Du X; Fan L; Bao Z; Sun G; Zhao P; Chao H; Li C; Zeng A; Pan M; Ji J
J Cell Mol Med; 2019 Oct; 23(10):6907-6918. PubMed ID: 31430050
[TBL] [Abstract][Full Text] [Related]
10. Annexins A2 and A5 are potential early biomarkers of hepatocarcinogenesis.
Herrera-López EE; Guerrero-Escalera D; Aguirre-Maldonado I; López-Hernández A; Montero H; Gutiérrez-Nava MA; Del Pozo-Yauner L; Arellanes-Robledo J; Camacho J; Pérez-Carreón JI
Sci Rep; 2023 Apr; 13(1):6948. PubMed ID: 37117324
[TBL] [Abstract][Full Text] [Related]
11. Comprehensive Analysis of CD163 as a Prognostic Biomarker and Associated with Immune Infiltration in Glioblastoma Multiforme.
Li H; Wang D; Yi B; Cai H; Xi Z; Lou X; Li Z
Biomed Res Int; 2021; 2021():8357585. PubMed ID: 34395626
[TBL] [Abstract][Full Text] [Related]
12. Annexin10 promotes extrahepatic cholangiocarcinoma metastasis by facilitating EMT via PLA2G4A/PGE2/STAT3 pathway.
Sun R; Liu Z; Qiu B; Chen T; Li Z; Zhang X; Xu Y; Zhang Z
EBioMedicine; 2019 Sep; 47():142-155. PubMed ID: 31492557
[TBL] [Abstract][Full Text] [Related]
13. Expression profile and distribution of Annexin A1, A2 and A5 in human semen.
Munuce MJ; Marini PE; Teijeiro JM
Andrologia; 2019 Mar; 51(2):e13224. PubMed ID: 30614025
[TBL] [Abstract][Full Text] [Related]
14. Expression and prognostic significance of TCTN1 in human glioblastoma.
Meng D; Chen Y; Zhao Y; Wang J; Yun D; Yang S; Chen J; Chen H; Lu D
J Transl Med; 2014 Oct; 12():288. PubMed ID: 25304031
[TBL] [Abstract][Full Text] [Related]
15. Systematic identification, development, and validation of prognostic biomarkers involving the tumor-immune microenvironment for glioblastoma.
Zhao B; Wang Y; Wang Y; Chen W; Liu PH; Kong Z; Dai C; Wang Y; Ma W
J Cell Physiol; 2021 Jan; 236(1):507-522. PubMed ID: 32572951
[TBL] [Abstract][Full Text] [Related]
16. Annexin A8 can serve as potential prognostic biomarker and therapeutic target for ovarian cancer: based on the comprehensive analysis of Annexins.
Gou R; Zhu L; Zheng M; Guo Q; Hu Y; Li X; Liu J; Lin B
J Transl Med; 2019 Sep; 17(1):275. PubMed ID: 31474227
[TBL] [Abstract][Full Text] [Related]
17. Annexin A10 is a novel prognostic biomarker of papillary thyroid cancer.
Liu X; Yang M; Guo Y; Lu X
Ir J Med Sci; 2021 Feb; 190(1):59-65. PubMed ID: 32451762
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of annexin A2 and annexin A4 expression in patients with cervical cancer.
Choi CH; Chung JY; Chung EJ; Sears JD; Lee JW; Bae DS; Hewitt SM
BMC Cancer; 2016 Jul; 16():448. PubMed ID: 27402115
[TBL] [Abstract][Full Text] [Related]
19. Identification of Prognostic Biomarkers for Glioblastoma Based on Transcriptome and Proteome Association Analysis.
Wang J; Yan S; Chen X; Wang A; Han Z; Liu B; Shen H
Technol Cancer Res Treat; 2022; 21():15330338211035270. PubMed ID: 35538679
[TBL] [Abstract][Full Text] [Related]
20. TRAF6 correlated to invasion and poor prognosis of glioblastoma via elevating MMP9 expression.
Sun J; Zhao B; Du K; Liu P
Neuroreport; 2019 Jan; 30(2):127-133. PubMed ID: 30571666
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]